Retroperitoneal Hemorrhage in Patients with COVID-19 Undergoing Hemodialysis: Three Case Reports

A 73-year-old man receiving hemodialysis and antiplatelets was admitted with a mild case of COVID-19. Heparin was added, and iliopsoas hemorrhage developed. He was successfully treated by interventional radiology. A 76-year-old man receiving hemodialysis and antiplatelets was admitted with mild COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Oka, Hideaki, Homma, Yoshito, Nishino, Yuki, Suemori, Koichiro, Sato, Norio, Sakurai, Yuko, Sekimoto, Mizuki, Ando, Shota, Iwamoto, Saki, Iwamoto, Takaki, Kondo, Mika, Kamimura, Taro, Nakano, Toshiaki, Kitazono, Takanari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259805/
https://www.ncbi.nlm.nih.gov/pubmed/35400699
http://dx.doi.org/10.2169/internalmedicine.8976-21
Descripción
Sumario:A 73-year-old man receiving hemodialysis and antiplatelets was admitted with a mild case of COVID-19. Heparin was added, and iliopsoas hemorrhage developed. He was successfully treated by interventional radiology. A 76-year-old man receiving hemodialysis and antiplatelets was admitted with mild COVID-19. Heparin was added, and iliacus hemorrhage developed. Despite heparin discontinuation, he died of worsening pneumonia. A 74-year-old man undergoing hemodialysis was admitted with severe COVID-19. Gastrointestinal bleeding developed during continuous hemodiafiltration with heparin. Upon switching to nafamostat and increasing the dose, iliopsoas hemorrhage developed. Despite interventional radiology, he died of infectious complications. Attention to hemorrhagic complications is therefore needed in patients with COVID-19.

Ejemplares similares